INS and hepatocellular carcinoma: Interestingly, dexamethasone, a synthetic glucocorticoid, significantly reduced insulin binding to IDE without affecting expression levels of the protease in rat hepatoma cells, most likely by inducing a conformational change or blocking insulin-binding sites [117].